Definitive Contract 75F40124C00075
Award Date
7/17/24
Potential Completion Date
8/6/25
Potential Value
$191K
Federal Agency
Food and Drug Administration
Awardee
Aneon Brillient, LLC
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
St. Louis, MO 63110, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This award represents a 1-year, $190,357.34 time and materials contract for information technology professional services awarded by the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture. The contract supports the Office of Pharmaceutical Quality within CDER. As an 8(a) sole source award, this contract leverages the SBA's business development program to provide specialized IT services to the...
This is a $192,142.38 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business certified as an 8(a) joint venture. The contract is for a Quality Assurance Specialist III position to support the FDA's Center for Drug Evaluation and Research (CDER) and Office of Pharmaceutical Quality (OPQ). The work will be performed in Calverton, Maryland and has an ultimate completion date of August 29, 2025....
This is a 3-year, labor-hour contract for $3,120,771.46 awarded by the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for communication, administrative, and information disclosure support services. The contract is a direct 8(a) sole source award, leveraging Aneon Brillient's 8(a) status. Aneon Brillient is a minority-owned, small disadvantaged business that provides...
This is a direct 8(a) sole source award of a 12-month base and 9-month option, labor hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services. The contract has a ceiling value of $4,277,014.63 and an ultimate completion date of May 31, 2026. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The company has a history of...
This is a $642,543.27 definitive contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, an 8(a) certified small disadvantaged business, to provide transcription services to support the Center for Drug Evaluation and Research (CDER) advisory committee meetings. The contract has a completion date of February 27, 2026 and is a sole source award under the 8(a) program. Aneon Brillient specializes in providing professional services to the FDA, including medical and...
The U.S. Food and Drug Administration (FDA) awarded a 4-year, labor-hour type contract worth $2,133,514.80 to Aneon Brillient, LLC, a Small Disadvantaged Business and 8(a) Joint Venture. The contract is for medical and scientific writing and editing services to support the FDA's Center for Drug Evaluation and Research (CDER). This award was a direct 8(a) sole source contract and did not have a set-aside designation. Aneon Brillient has a history of providing professional services to the FDA,...
This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
This is a 3-year, labor-hour type contract awarded to Aneon Brillient, LLC, an 8(a) certified small disadvantaged business, for program support services for the U.S. Food and Drug Administration (FDA) Office of Policy, Legislation and International Affairs (OPLIA). The $3,631,037.49 contract was awarded on a sole source basis through the 8(a) program. Aneon Brillient is a minority-owned limited liability company that specializes in providing professional services to the FDA, including support...
The U.S. Food and Drug Administration (FDA) awarded a $229,132.68 labor-hour purchase order to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture company, to provide webmaster, technical, and creative support to enhance and maintain the Office of Translational and Emerging Technologies' (OTED) online presence. This 8(a) sole source set-aside contract has an ultimate completion date of August 14, 2025. Aneon Brillient, LLC is a minority-owned, small disadvantaged business that...
The U.S. Food and Drug Administration (FDA) has awarded an 8(a) sole source, labor-hour contract to Aneon Brillient, LLC to provide Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). The contract has a ceiling value of $1,479,584.76 and a period of performance through August 27, 2025. Aneon Brillient, a minority-owned small disadvantaged business certified as an 8(a) joint venture, has a strong ongoing relationship with the...